The effect of the Ginger dry extract on the indicators of the carbohydrate metabolism under conditions of the experimental metabolic syndrome in Syrian golden hamsters
DOI:
https://doi.org/10.24959/nphj.18.2200Keywords:
Ginger dry extract, metabolic syndrome, high-calorie diet, carbohydrate metabolismAbstract
Aim. To study the effect of the ginger dry extract on the indicators of the carbohydrate metabolism in the experimental metabolic syndrome.
Materials and methods. The effect of the ginger dry extract on the carbohydrate metabolism was determined by the level of basal glycemia, basal insulinemia, HOMA-IR index, HbA1c level, the glycogen content in the liver and the body weight against the background of the metabolic syndrome induced by a high-calorie diet in Syrian golden hamsters.
Results and discussion. Consumption of high-calorie food for 6 weeks led to development of the metabolic syndrome, it was confirmed by an increase in the body weight, hyperglycemia, compensatory insulinemia, insulin resistance, increased glycogenolysis in the liver and glycosylation of proteins. The use of the ginger dry extract in the dose of 80 mg/kg over the period of 14 days reliably reduced blood glucose by 43.3 % and normalized insulinemia by 32.8 % affecting a decrease in the HOMA-IR index. The introduction of the ginger extract in the dose of 80 mg/kg was also accompanied by suppression of protein glycosylation by 29.6 % and restoration of glycogen-forming function of the liver. By its ability to restore the carbohydrate metabolism the ginger dry extract in the dose of 80 mg/kg did not differ from metformin and exceeded the effectiveness of the herbal drug “Arphasetin”. It is probably due to the powerful complex pharmacological action of phenolic compounds of ginger – gingerols and other components.
Conclusions. On the experimental model of the metabolic syndrome the use of the ginger dry extract normalized blood glucose, insulinemia, decreased insulin resistance and restored the glycogen content in the liver at the level of metformin. By the intensity of the pharmacological action the ginger extract exceeded the reference herbal drug “Arphasetin”. This fact is the basis for its further pharmacological study as a promising agent for the treatment of the metabolic syndrome and type 2 diabetes.
References
Tkachenko, V. I., Bahro, T. O., Vydyborets, N. V., Bondar, O. K. (2016). Liky Ukraini, 1–2 (197–198), 43–46.
Sokolova, L. К., Pushkarev, V. M., Kovzun, E. I., Pushkarev, V. V., Tronko, N. D. (2017). Ukrainskyi kardiolohichnyi zhurnal, 6, 104–117.
Voloshyn, O. I., Bachuk–Ponych, N. V., Voloshyna, L. O., Vasiuk, V. O. (2012). Fitoterapiia. Chasopys, 2, 19–22.
Ilkhanizadeh, B., Shirpoor, A., Khadem Ansari, M. hasan, Nemati, S., Rasmi, Y. (2016). Protective Effects of Ginger (Zingiber officinale) Extract against Diabetes–Induced Heart Abnormality in Rats. Diabetes & Metabolism Journal, 40 (1), 46. doi: 10.4093/dmj.2016.40.1.46
Madkor, H. R., Mansour, S. W., Ramadan, G. (2010). Modulatory effects of garlic, ginger, turmeric and their mixture on hyperglycaemia, dyslipidaemia and oxidative stress in streptozotocin–nicotinamide diabetic rats. British Journal of Nutrition, 105 (08), 1210–1217. doi: 10.1017/s0007114510004927
Zagayko, A., Kravchenko, G., Strelchenko, K., Shkapo, A., Briukhanova, T. (2015). Sex and Age Differences in Lipoprotein Metabolism Proatherogenic Changes under the Experimental Metabolic Syndrome in Hamsters. Lipoproteins – From Bench to Bedside. doi: 10.5772/60759
Stefanov, O. V. (2001). Doklіnіchnі doslіdzhennia lіkarskykh zasobіv. Kyiv: Avіtsena, 528.
Matthews, D. R., Hosker, J. P., Rudenski, A. S., Naylor, B. A., Treacher, D. F., Turner, R. C. (1985). Homeostasis model assessment: insulin resistance and b–cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia, 28 (7), 412–419. doi: 10.1007/bf00280883
Prokhorova, M. I. (1982). Metody biokhimicheskikh issledovanii. Lipidnyi i energeticheskyi obmen. L.: Leningradskii un–t, 272.
Fadeenko, G. D., Gridnev, A. E. (2009). Liky Ukrainy, 133 (7), 55–64.
Antonova, K. V., Medvedev, R. B., Shabalina, A. A., Lagoda, O. V., Tanashian, M. M. (2016). Klinicheskaia nevrologiia, 10 (1), 20–26.
Downloads
Published
Issue
Section
License
Copyright (c) 2018 National University of Pharmacy
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
